SCHEMBL7517549

SCHEMBL7517549

CCCc1ccc(NC2=CC(=O)OC2)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 2/20 0.38
KMT2A Q03164 4/20 0.37
PKM P14618 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.34
MAPK1 P28482 1/20 0.34
POLB P06746 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 1/20 0.32
IDO1 P14902 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPK14 Q16539 1/20 0.31
ALOX5 P09917 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522665 0.93 CTRC (0.39) P2RX3KMT2APKML3MBTL1MEN1
SCHEMBL7517906 0.91 KMT2A (0.38) KMT2APKML3MBTL1MEN1MAPT
SCHEMBL29926760 0.81 RAB9A (0.40) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL28463421 0.81 RAB9A (0.40) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL7524238 0.80 RAPGEF4 (0.46) KMT2APKML3MBTL1MEN1MAPT
SCHEMBL7523160 0.77 MAPT (0.37) P2RX3KMT2APKML3MBTL1MEN1
SCHEMBL7558368 0.77 P2RX3 (0.38) P2RX3KMT2APKML3MBTL1MEN1
SCHEMBL7518027 0.75 RAB9A (0.45) KMT2AMEN1MAPTMAPK1POLB
SCHEMBL7524987 0.74 PPIA (0.46) KMT2APKMMEN1MAPTPOLB
SCHEMBL7524917 0.74 ULK1 (0.39) KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed